The biotech scrap heap isn't always the most promising place to go shopping, but biotech giant Amgen (AMGN)
is going to give it a try, announcing on Monday that it will acquire
Iceland's deCODE Genetics for $415 million in cash. That's a pretty
stunning reversal for a company that sold for $14 million not so long
ago, and it remains to be seen whether Amgen can find the key to unlock
the value that many have seen in deCODE's approach for more than a
decade.
Please read more here:
Can Amgen Unlock DeCODE's Value?
No comments:
Post a Comment